Whitehouse PJ (2006)
Quality of life: the bridge from the cholinergic basal forebrain to cognitive science and bioethics
J Alzheimers Dis 9: 447

Yesavage JA, Mumenthaler MS, Taylor JL, Friedman L, O'Hara R, Sheikh J, Tinklenberg J, Whitehouse PJ (2002)
Donepezil and flight simulator performance: effects on retention of complex skills
Neurology 59: 123

Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL (2001)
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology 56: 1154

Whitehouse PJ (1999)
Alzheimer's disease: past, present, and future
European Archives of Psychiatry & Clinical Neuroscience 3: 43

Whitehouse PJ, Arizaga R, Brodaty H, Gauthier S, Graham N, Green RC, Homma A, Mangone C, Senanarong V, Xu XH (1999)
Placebos in clinical trials in Alzheimer disease: an international discussion
Alzheimer Disease & Associated Disorders 13: 121

Karlawish JH, Whitehouse PJ (1998)
Is the placebo control obsolete in a world after donepezil and vitamin E?
Archives of Neurology 55: 1420

Post SG, Whitehouse PJ (1998)
Emerging antidementia drugs: a preliminary ethical view [see comments]
J Am Geriatr Soc 46: 784

Smith AL, Whitehouse PJ (1998)
Progress in the management of Alzheimer's disease
Hosp Pract 33: 151

Whitehouse PJ (1998)
Drugs Today (Barc) 34: 321

Whitehouse PJ, Winblad B, Shostak D, Bhattacharjya A, Brod M, Brodaty H, Dor A, Feldman H, Forette F, Gauthier S, Hay J, Henke C, Hill S, Mastey V, Neumann P, O'Brien B, Pugner K, Sano M, Sawada T, Stone R, Wimo A (1998)
First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary
Alzheimer Disease & Associated Disorders 12: 266

Whitehouse PJ, Juengst E, Mehlman M, Murray TH (1997)
Enhancing cognition in the intellectually intact
Hastings Center Report 27: 14

Whitehouse PJ (1997)
Pharmacoeconomics of dementia
Alzheimer Disease & Associated Disorders 11: S32

Whitehouse PJ, Sciulli CG, Mason RM (1997)
Dementia drug development: use of information systems to harmonize global drug development
Psychopharmacol Bull 33: 129

Whitehouse PJ, Voci J (1995)
Therapeutic trials in Alzheimer's disease
Curr Opin Neurol 8: 275

Whitehouse PJ, Geldmacher DS (1994)
Pharmacotherapy for Alzheimer's disease
Clin Geriatr Med 10: 339

Whitehouse PJ (1993)
Cholinergic therapy in dementia
Acta Neurologica Scandinavica Supplementum 149: 42

Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, et al. (1992)
A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group
N Engl J Med 327: 1253

Casanova MF, Struble RG, Whitehouse PJ, Price DL (1988)
A historical perspective on the neuropathology of dementia with emphasis on the senile plaque
Bol Asoc Med P R 80: 424

Powers RE, Walker LC, DeSouza EB, Vale WW, Struble RG, Whitehouse PJ, Price DL (1987)
Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease
Synapse 1: 405

Price DL, Cork LC, Struble RG, Kitt CA, Walker LC, Powers RE, Whitehouse PJ, Griffin JW (1987)
Dysfunction and death of neurons in human degenerative neurological diseases and in animal models
Ciba Found Symp 126: 30

Price DL, Struble RG, Whitehouse PJ, Kitt CA, Cork LC, Walker LC, Casanova MF (1986)
Alzheimer's disease: a multisystem disorder
Res Publ Assoc Res Nerv Ment Dis 64: 209

Price DL, Kitt CA, Hedreen JC, Whitehouse PJ, Struble RG, Cork LC, Walker LC, Mobley WC, Crawford GD, Salvaterra PM, Wainer BH (1986)
Basal Forebrain Cholinergic Systems in Primate Brain: Anatomical Organization and Role in the Pathology of Aging and Dementia
Advances in Behavioral Biology 30: 235

Price DL, Cork LC, Struble RG, Whitehouse PJ, Kitt CA, Walker LC (1985)
The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease
Annals of the New York Academy of Sciences 444: 287

Price DL, Kitt CA, Struble RG, Whitehouse PJ, Cork LC, Walker LC (1985)
Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia
Annals of the New York Academy of Sciences 457: 35

Price DL, Whitehouse PJ, Struble RG (1985)
Alzheimer's disease
Annu Rev Med 36: 349

Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, Price DL (1985)
Alzheimer's disease and related dementias: selective involvement of specific neuronal systems
CRC Crit Rev Clin Neurobiol 1: 319

Whitehouse PJ, Trifiletti RR, Jones BE, Folstein S, Price DL, Snyder SH, Kuhar MJ (1985)
Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes
Annals of Neurology 18: 202

Hedreen JC, Struble RG, Whitehouse PJ, Price DL (1984)
Topography of the magnocellular basal forebrain system in human brain
J Neuropathol Experimental Neurology 43: 1

Whitehouse PJ, Struble RG, Hedreen JC, Clark AW, White CL, Parhad IM, Price DL (1983)
Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease
Psychopharmacol Bull 19: 437

Price DL, Whitehouse PJ, Struble RG, Coyle JT, Clark AW, DeLong MR, Cork LC, Hedreen JC (1982)
Alzheimer's disease and Down's syndrome
Annals of the New York Academy of Sciences 396: 145

Struble RG, Cork LC, Whitehouse PJ, Price DL (1982)
Cholinergic innervation in neuritic plaques
Science 216: 413

Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982)
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain
Science 215: 1237

Whitehouse PJ, Struble RG, Clark AW, Price DL (1982)
Alzheimer disease: plaques, tangles, and the basal forebrain
Annals of Neurology 12: 494